Nurun Fancy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nurun Fancy has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Paul McMahan Matthews
Imperial College, London
14 shared publications - Johanna S. Jackson
UK Dementia Research Institute, Imperial College London, UK
11 shared publications Marianna Papageorgopoulou
UK Dementia Research Institute at Imperial College London, London, UK
5 shared publicationsAisling McGarry
UK Dementia Research Institute at Imperial College London, London, UK
4 shared publicationsMichael Thomas
UK Dementia Research Institute, Imperial College London, UK
4 shared publications- Nanet Willumsen
UK Dementia Research Institute Centre at Imperial College London and Department of Brain Sciences, 728 Sir Michael Uren Research Hub, 86 Wood Ln, London, UK
4 shared publications
Latest Publications
- Open Access
Neuronal and glial transcriptional states vary with proximity to tangle-bearing neurons in the human entorhinal cortex
Summary: More neurons die in Alzheimer’s disease than form tangles, and tangle-bearing neurons can persist for decades, so tangles alone cannot explain degeneration. We combined 6,000-plex spatial transcriptomics with PHF1 immunofluorescence (167,176 cells; 9 donors) and imaging mass cytometry (170,195 cells; 62 donors), measuring each cell’s distance to the nearest tangle. Tangle-bearing layer 2-3 excitatory neurons were enriched late along a trajectory of increasing microtubule-associated, synaptic and V-ATPase expression, with elevated p62 and K48-ubiquitin. Tangle-free neurons shared more of this state the closer they lay to a tangle, including higher chaperone and autophagy scores, p62 and nuclear size. Nearby glia had higher disease- associated scores, with astrocytes expressing less GFAP. Excitatory, but not inhibitory, neuron loss was greatest in subtypes closest to tangles and cortical depths richest in phosphorylated tau. Selective neuronal vulnerability may reflect not only a neuron’s susceptibility to forming a tangle but also where it lies relative to one. Highlights: Single-cell spatial analysis defines a tangle microenvironment in human cortex Tangle-free neurons near tangles have higher stress and autophagy gene expression Microglia and astrocytes near tangles show disease-associated reactive signatures Excitatory neuron loss is concentrated where local phosphorylated tau is highest
Open AccessNeuronal and glial transcriptional states vary with proximity to tangle-bearing neurons in the human entorhinal cortex
Summary: More neurons die in Alzheimer’s disease than form tangles, and tangle-bearing neurons can persist for decades, so tangles alone cannot explain degeneration. We combined 6,000-plex spatial transcriptomics with PHF1 immunofluorescence (167,176 cells; 9 donors) and imaging mass cytometry (170,195 cells; 62 donors), measuring each cell’s distance to the nearest tangle. Tangle-bearing layer 2-3 excitatory neurons were enriched late along a trajectory of increasing microtubule-associated, synaptic and V-ATPase expression, with elevated p62 and K48-ubiquitin. Tangle-free neurons shared more of this state the closer they lay to a tangle, including higher chaperone and autophagy scores, p62 and nuclear size. Nearby glia had higher disease- associated scores, with astrocytes expressing less GFAP. Excitatory, but not inhibitory, neuron loss was greatest in subtypes closest to tangles and cortical depths richest in phosphorylated tau. Selective neuronal vulnerability may reflect not only a neuron’s susceptibility to forming a tangle but also where it lies relative to one. Highlights: Single-cell spatial analysis defines a tangle microenvironment in human cortex Tangle-free neurons near tangles have higher stress and autophagy gene expression Microglia and astrocytes near tangles show disease-associated reactive signatures Excitatory neuron loss is concentrated where local phosphorylated tau is highest
- Open Access
- 31 August 2026
- Published by Wiley in Advanced Science
- p. e77453
Tau Aggregate Imaging and Transcriptomics of Alzheimer's Disease Brain at Different Stages of Disease
Tau aggregation plays a critical role in the development and progression of Alzheimer's disease (AD). Tau aggregates of different sizes and shapes are formed, which ultimately lead to the deposition of fibrillar tangles. We used single‐molecule techniques to characterize tau aggregates in the middle temporal gyrus and somatosensory cortex in post‐mortem brain homogenates at different Braak stages from patients with AD. Total and phosphorylated tau aggregates increased dramatically in late Braak stages. The aggregates showed greater multi‐site phosphorylation with increased Braak stage, but there was only a moderate change in the aggregate size distribution. Paired single nuclei transcriptomic analyses provided evidence for greater pro‐inflammatory microglial and complement pathway activation with increasing phosphorylated tau aggregate concentration and length. Based on this correlation, we hypothesize a cascade of disease progression in which microglial inflammation induces tau aggregation in neighboring neurons that, in turn, further enhances inflammation and the spread of tau pathology to increase the concentration of small tau aggregates.
- 31 August 2026
- Published by Wiley in Advanced Science
- p. e77453
Open AccessTau Aggregate Imaging and Transcriptomics of Alzheimer's Disease Brain at Different Stages of Disease
Tau aggregation plays a critical role in the development and progression of Alzheimer's disease (AD). Tau aggregates of different sizes and shapes are formed, which ultimately lead to the deposition of fibrillar tangles. We used single‐molecule techniques to characterize tau aggregates in the middle temporal gyrus and somatosensory cortex in post‐mortem brain homogenates at different Braak stages from patients with AD. Total and phosphorylated tau aggregates increased dramatically in late Braak stages. The aggregates showed greater multi‐site phosphorylation with increased Braak stage, but there was only a moderate change in the aggregate size distribution. Paired single nuclei transcriptomic analyses provided evidence for greater pro‐inflammatory microglial and complement pathway activation with increasing phosphorylated tau aggregate concentration and length. Based on this correlation, we hypothesize a cascade of disease progression in which microglial inflammation induces tau aggregation in neighboring neurons that, in turn, further enhances inflammation and the spread of tau pathology to increase the concentration of small tau aggregates.
- Open Access
- 27 August 2026
- Published by Springer Nature in Research Square
Quantitative adaptor heterogeneity sets single-cell thresholds for innate immune activation and attenuation
Macrophages exhibit a range of time-dependent responses to external stimuli, but at the single cell-level how receptor input is converted into heterogeneous inflammatory outputs, and how termination occurs remains unclear. Toll-like receptor (TLR) signaling is initiated through supramolecular protein assemblies. In this work, using macrophages with endogenously tagged myeloid differentiation primary response 88 (MyD88), and in primary mouse macrophages, we identify pre-existing heterogeneity in MyD88 abundance as a hidden single-cell variable that shapes the threshold for productive MyD88 assembly and downstream signaling. Strong agonism converts this basal heterogeneity into rapid growth of large MyD88 assemblies, robust NFκB activation, cytokine production, and induction of negative regulators. In contrast, weak agonism produces delayed and less efficient assembly, low-amplitude cytokine output, and weaker feedback engagement, resulting in persistent low-output signaling. Parallel transcriptomic analysis of Alzheimer's disease (AD) brain tissue, and blood samples across additional acute and chronic inflammatory disease cohorts, reveals a consistent, disproportionate activation-relative-to-feedback signature, suggesting incomplete activation-feedback coupling as a correlative but recurring feature of chronic inflammatory disease.
- 27 August 2026
- Published by Springer Nature in Research Square
Open AccessQuantitative adaptor heterogeneity sets single-cell thresholds for innate immune activation and attenuation
Macrophages exhibit a range of time-dependent responses to external stimuli, but at the single cell-level how receptor input is converted into heterogeneous inflammatory outputs, and how termination occurs remains unclear. Toll-like receptor (TLR) signaling is initiated through supramolecular protein assemblies. In this work, using macrophages with endogenously tagged myeloid differentiation primary response 88 (MyD88), and in primary mouse macrophages, we identify pre-existing heterogeneity in MyD88 abundance as a hidden single-cell variable that shapes the threshold for productive MyD88 assembly and downstream signaling. Strong agonism converts this basal heterogeneity into rapid growth of large MyD88 assemblies, robust NFκB activation, cytokine production, and induction of negative regulators. In contrast, weak agonism produces delayed and less efficient assembly, low-amplitude cytokine output, and weaker feedback engagement, resulting in persistent low-output signaling. Parallel transcriptomic analysis of Alzheimer's disease (AD) brain tissue, and blood samples across additional acute and chronic inflammatory disease cohorts, reveals a consistent, disproportionate activation-relative-to-feedback signature, suggesting incomplete activation-feedback coupling as a correlative but recurring feature of chronic inflammatory disease.
- Open Access
- 17 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Characterising processing conditions that artifactually bias human brain tissue transcriptomes
Autopsy-derived brain tissue analysis is crucial for understanding neurobiology, but post-mortem handling can introduce artifacts. We studied adult human brain transcriptomic signatures from tissue immediately extracted from brains (< 0 hours) and compared to autopsy brain tissue with short (~6 hours) and long (~36 hours) post-mortem intervals (PMIs). Significant deviations in gene signatures were observed in both short and long PMIs compared to immediately extracted tissue, which we defined as Brain Artifact Genes (BAGs). By subjecting brain samples to processing variables that are unavoidable in autopsy programs (post-mortem time and temperature), we characterized a set of artifact-responsive genes and mapped this signature onto matched single-nucleus RNA-seq data, revealing that it was predominantly glutamatergic neurons that exhibited the earliest induction of artifact genes followed by oligodendrocytes later. Using deep learning, we distilled this broader processing-response program into a predictive signature, called Time and Temperature Response genes Underlying Transcriptional Heterogeneity (TTRUTH) and provide an Open Science tool for assigning TTRUTH scores to brain RNA-seq data. Together, this work will help better standardize datasets, enable additional sample stratification, and enhance data interpretation.
- 17 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessCharacterising processing conditions that artifactually bias human brain tissue transcriptomes
Autopsy-derived brain tissue analysis is crucial for understanding neurobiology, but post-mortem handling can introduce artifacts. We studied adult human brain transcriptomic signatures from tissue immediately extracted from brains (< 0 hours) and compared to autopsy brain tissue with short (~6 hours) and long (~36 hours) post-mortem intervals (PMIs). Significant deviations in gene signatures were observed in both short and long PMIs compared to immediately extracted tissue, which we defined as Brain Artifact Genes (BAGs). By subjecting brain samples to processing variables that are unavoidable in autopsy programs (post-mortem time and temperature), we characterized a set of artifact-responsive genes and mapped this signature onto matched single-nucleus RNA-seq data, revealing that it was predominantly glutamatergic neurons that exhibited the earliest induction of artifact genes followed by oligodendrocytes later. Using deep learning, we distilled this broader processing-response program into a predictive signature, called Time and Temperature Response genes Underlying Transcriptional Heterogeneity (TTRUTH) and provide an Open Science tool for assigning TTRUTH scores to brain RNA-seq data. Together, this work will help better standardize datasets, enable additional sample stratification, and enhance data interpretation.
- Open Access
- 4 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Intracellular accumulation of amyloid-ß is a marker of selective neuronal vulnerability in Alzheimer’s disease
Defining how amyloid-β and pTau together lead to neurodegeneration is fundamental to understanding Alzheimer’s disease (AD). We used imaging mass cytometry to identify neocortical neuronal subtypes lost with AD in post-mortem brain middle temporal gyri from non-diseased and AD donors. Here we showed that L5,6 RORB+FOXP2+ and L3,5,6 GAD1+FOXP2+ neurons, which accumulate amyloid-β intracellularly from early Braak stages, are selectively vulnerable to degeneration in AD, while L3 RORB+GPC5+ neurons, which accumulate pTau but not amyloid-β, are not lost even at late Braak stages. We discovered spatial associations between activated microglia and these vulnerable neurons and found that vulnerable RORB+FOXP2+ neuronal transcriptomes are enriched selectively for pathways involved in inflammation and glycosylation and, with progression to AD, also protein degradation. Our results suggest that the accumulation of intraneuronal amyloid-β, which is associated with glial inflammatory pathology, may contribute to the initiation of degeneration of these vulnerable neurons.
- 4 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Open AccessIntracellular accumulation of amyloid-ß is a marker of selective neuronal vulnerability in Alzheimer’s disease
Defining how amyloid-β and pTau together lead to neurodegeneration is fundamental to understanding Alzheimer’s disease (AD). We used imaging mass cytometry to identify neocortical neuronal subtypes lost with AD in post-mortem brain middle temporal gyri from non-diseased and AD donors. Here we showed that L5,6 RORB+FOXP2+ and L3,5,6 GAD1+FOXP2+ neurons, which accumulate amyloid-β intracellularly from early Braak stages, are selectively vulnerable to degeneration in AD, while L3 RORB+GPC5+ neurons, which accumulate pTau but not amyloid-β, are not lost even at late Braak stages. We discovered spatial associations between activated microglia and these vulnerable neurons and found that vulnerable RORB+FOXP2+ neuronal transcriptomes are enriched selectively for pathways involved in inflammation and glycosylation and, with progression to AD, also protein degradation. Our results suggest that the accumulation of intraneuronal amyloid-β, which is associated with glial inflammatory pathology, may contribute to the initiation of degeneration of these vulnerable neurons.
- Open Access
- 10 January 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (2) , 358-368
Cell state-dependent allelic effects and contextual Mendelian randomization analysis for human brain phenotypes
Gene expression quantitative trait loci are widely used to infer relationships between genes and central nervous system (CNS) phenotypes; however, the effect of brain disease on these inferences is unclear. Using 2,348,438 single-nuclei profiles from 391 disease-case and control brains, we report 13,939 genes whose expression correlated with genetic variation, of which 16.7–40.8% (depending on cell type) showed disease-dependent allelic effects. Across 501 colocalizations for 30 CNS traits, 23.6% had a disease dependency, even after adjusting for disease status. To estimate the unconfounded effect of genes on outcomes, we repeated the analysis using nondiseased brains (n = 183) and reported an additional 91 colocalizations not present in the larger mixed disease and control dataset, demonstrating enhanced interpretation of disease-associated variants. Principled implementation of single-cell Mendelian randomization in control-only brains identified 140 putatively causal gene–trait associations, of which 11 were replicated in the UK Biobank, prioritizing candidate peripheral biomarkers predictive of CNS outcomes.
- 10 January 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (2) , 358-368
Open AccessCell state-dependent allelic effects and contextual Mendelian randomization analysis for human brain phenotypes
Gene expression quantitative trait loci are widely used to infer relationships between genes and central nervous system (CNS) phenotypes; however, the effect of brain disease on these inferences is unclear. Using 2,348,438 single-nuclei profiles from 391 disease-case and control brains, we report 13,939 genes whose expression correlated with genetic variation, of which 16.7–40.8% (depending on cell type) showed disease-dependent allelic effects. Across 501 colocalizations for 30 CNS traits, 23.6% had a disease dependency, even after adjusting for disease status. To estimate the unconfounded effect of genes on outcomes, we repeated the analysis using nondiseased brains (n = 183) and reported an additional 91 colocalizations not present in the larger mixed disease and control dataset, demonstrating enhanced interpretation of disease-associated variants. Principled implementation of single-cell Mendelian randomization in control-only brains identified 140 putatively causal gene–trait associations, of which 11 were replicated in the UK Biobank, prioritizing candidate peripheral biomarkers predictive of CNS outcomes.
- Open Access
- 13 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Multi-trait association analysis reveals shared genetic loci between Alzheimer’s disease and cardiovascular traits
Several cardiovascular traits and diseases co-occur with Alzheimer’s disease. We mapped their shared genetic architecture using multi-trait genome-wide association studies. Subsequent fine-mapping and colocalisation highlighted 16 genetic loci associated with both Alzheimer’s and cardiovascular diseases. We prioritised rs11786896, which colocalised with Alzheimer’s disease, atrial fibrillation and expression of PLEC in the heart left ventricle, and rs7529220, which colocalised with Alzheimer’s disease, atrial fibrillation and expression of C1Q family genes. Single-cell RNA-sequencing data, co-expression network and protein-protein interaction analyses provided evidence for different mechanisms of PLEC, which is upregulated in left ventricular endothelium and cardiomyocytes with heart failure and in brain astrocytes with Alzheimer’s disease. Similar common mechanisms are implicated for C1Q in heart macrophages with heart failure and in brain microglia with Alzheimer’s disease. These findings highlight inflammatory and pleomorphic risk determinants for the co-occurrence of Alzheimer’s and cardiovascular diseases and suggest PLEC, C1Q and their interacting proteins as potential therapeutic targets.
- 13 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Open AccessMulti-trait association analysis reveals shared genetic loci between Alzheimer’s disease and cardiovascular traits
Several cardiovascular traits and diseases co-occur with Alzheimer’s disease. We mapped their shared genetic architecture using multi-trait genome-wide association studies. Subsequent fine-mapping and colocalisation highlighted 16 genetic loci associated with both Alzheimer’s and cardiovascular diseases. We prioritised rs11786896, which colocalised with Alzheimer’s disease, atrial fibrillation and expression of PLEC in the heart left ventricle, and rs7529220, which colocalised with Alzheimer’s disease, atrial fibrillation and expression of C1Q family genes. Single-cell RNA-sequencing data, co-expression network and protein-protein interaction analyses provided evidence for different mechanisms of PLEC, which is upregulated in left ventricular endothelium and cardiomyocytes with heart failure and in brain astrocytes with Alzheimer’s disease. Similar common mechanisms are implicated for C1Q in heart macrophages with heart failure and in brain microglia with Alzheimer’s disease. These findings highlight inflammatory and pleomorphic risk determinants for the co-occurrence of Alzheimer’s and cardiovascular diseases and suggest PLEC, C1Q and their interacting proteins as potential therapeutic targets.
- Open Access
- 23 October 2024
- Published by Springer Nature in Research Square
Characterising processing conditions that artifactually bias human brain tissue transcriptomes
Autopsy-derived brain tissue analysis is vital for exploring the complex landscape of neurobiology in health and disease but processing conditions during post-mortem handling can lead to significant technical artifacts affecting data interpretation. Here, we define brain transcriptomic signatures from healthy adult human brain tissue that was snap frozen in under 1 hour (Mean: 31min, Min: 10min, Max 55min) of extraction (hereafter referred to as ~ 0 hours) and compared it to brain autopsy tissue with either typical shorter (Mean: 6 hours, Min: 4h, Max: 14h) or longer (Mean: 36 hours, Min: 17h, Max: 70h) post-mortem intervals. We found a large number of differentially expressed genes in post-mortem tissue compared to snap frozen tissue, even with the shorter post-mortem intervals. These differences allowed us to define a general “artifactual” gene signature from adult human brain autopsies that arise as a result of post-mortem processing (termed B rain A rtifact G ene ( BAG ) Signatures). We subjected the snap frozen brain samples to different times and temperatures mimicking those typical with autopsy material to determine how these common variables influence brain gene expression. Using this approach, we discovered a set of regulated genes that we defined as “ T ime and T emperature R esponse genes U nderlying T ranscriptional H eterogeneity (TTRUTH)” genes. Using deep learning approaches, we then developed a model capable of modelling the extent to which individual brain autopsy samples from non-neurological disease control donors express artifactual transcripts associated with post-mortem interval time and temperature. This allowed us to assign TTRUTH scores to each individual brain autopsy sample. Moreover, using single nuclear RNA sequencing on paired samples, we identified that neuronal populations are the initial expressers of these artifactual transcripts. As tissue remains at room temperature for extended periods, oligodendrocytes emerge as the predominant cell types expressing artifactual genes. Finally, we provide an Open Science website tool for others to use to determine whether their samples are subject to similar artifacts. Using this tool, the brain autopsy research community can now assign TTRUTH scores to human brain autopsy RNAseq datasets, to provide an additional quality control measure to better standardise datasets, allow additional sample stratification across experimental groups and enhance data interpretation.
- 23 October 2024
- Published by Springer Nature in Research Square
Open AccessCharacterising processing conditions that artifactually bias human brain tissue transcriptomes
Autopsy-derived brain tissue analysis is vital for exploring the complex landscape of neurobiology in health and disease but processing conditions during post-mortem handling can lead to significant technical artifacts affecting data interpretation. Here, we define brain transcriptomic signatures from healthy adult human brain tissue that was snap frozen in under 1 hour (Mean: 31min, Min: 10min, Max 55min) of extraction (hereafter referred to as ~ 0 hours) and compared it to brain autopsy tissue with either typical shorter (Mean: 6 hours, Min: 4h, Max: 14h) or longer (Mean: 36 hours, Min: 17h, Max: 70h) post-mortem intervals. We found a large number of differentially expressed genes in post-mortem tissue compared to snap frozen tissue, even with the shorter post-mortem intervals. These differences allowed us to define a general “artifactual” gene signature from adult human brain autopsies that arise as a result of post-mortem processing (termed B rain A rtifact G ene ( BAG ) Signatures). We subjected the snap frozen brain samples to different times and temperatures mimicking those typical with autopsy material to determine how these common variables influence brain gene expression. Using this approach, we discovered a set of regulated genes that we defined as “ T ime and T emperature R esponse genes U nderlying T ranscriptional H eterogeneity (TTRUTH)” genes. Using deep learning approaches, we then developed a model capable of modelling the extent to which individual brain autopsy samples from non-neurological disease control donors express artifactual transcripts associated with post-mortem interval time and temperature. This allowed us to assign TTRUTH scores to each individual brain autopsy sample. Moreover, using single nuclear RNA sequencing on paired samples, we identified that neuronal populations are the initial expressers of these artifactual transcripts. As tissue remains at room temperature for extended periods, oligodendrocytes emerge as the predominant cell types expressing artifactual genes. Finally, we provide an Open Science website tool for others to use to determine whether their samples are subject to similar artifacts. Using this tool, the brain autopsy research community can now assign TTRUTH scores to human brain autopsy RNAseq datasets, to provide an additional quality control measure to better standardise datasets, allow additional sample stratification across experimental groups and enhance data interpretation.
- Open Access
Integrative multi-omics reveal glial signatures associated with accelerated cognitive decline in Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by progressive cognitive decline and memory loss caused by both genetic and environmental factors. Synapse dysfunction and loss are strongly related to cognitive decline in AD. This study integrates genomic, transcriptomic, proteomic and immunohistological (multi-omics) data and longitudinal cognitive data across several AD cohorts to elucidate the molecular drivers associated with astrocytes and microglia involved in these processes. Our findings demonstrate that activation of microglia and astrocytes occurs in specific cell subsets that are enriched in AD risk genes. Transcriptomic evidence for early microglial activation precedes immunohistological expression of severe neuropathology. Proteomic markers of astrocytic response appear to be most strongly associated with accelerated cognitive decline. However, we also found that brains from donors with a history of more rapid cognitive decline showed evidence for reduced SNAP25-VAMP interactions indicative of synaptic dysfunction, exhibited higher neurotoxic astrocyte reactivity, and were associated with the expression of neuronal markers of injury. Related molecular signatures in cerebrospinal fluid and plasma may provide biomarkers to identify patients at higher risk for rapid cognitive decline. Together, our results connect glial activation to synaptic dysfunction and cognitive decline in AD and highlight roles for microglial activation in the genesis of AD and later astrocyte activation as a potential determinant of clinical symptom progression.
Open AccessIntegrative multi-omics reveal glial signatures associated with accelerated cognitive decline in Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by progressive cognitive decline and memory loss caused by both genetic and environmental factors. Synapse dysfunction and loss are strongly related to cognitive decline in AD. This study integrates genomic, transcriptomic, proteomic and immunohistological (multi-omics) data and longitudinal cognitive data across several AD cohorts to elucidate the molecular drivers associated with astrocytes and microglia involved in these processes. Our findings demonstrate that activation of microglia and astrocytes occurs in specific cell subsets that are enriched in AD risk genes. Transcriptomic evidence for early microglial activation precedes immunohistological expression of severe neuropathology. Proteomic markers of astrocytic response appear to be most strongly associated with accelerated cognitive decline. However, we also found that brains from donors with a history of more rapid cognitive decline showed evidence for reduced SNAP25-VAMP interactions indicative of synaptic dysfunction, exhibited higher neurotoxic astrocyte reactivity, and were associated with the expression of neuronal markers of injury. Related molecular signatures in cerebrospinal fluid and plasma may provide biomarkers to identify patients at higher risk for rapid cognitive decline. Together, our results connect glial activation to synaptic dysfunction and cognitive decline in AD and highlight roles for microglial activation in the genesis of AD and later astrocyte activation as a potential determinant of clinical symptom progression.
- Top Cited PapersOpen Access
- 12 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-19
A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer’s disease
Brain perfusion and blood-brain barrier (BBB) integrity are reduced early in Alzheimer’s disease (AD). We performed single nucleus RNA sequencing of vascular cells isolated from AD and non-diseased control brains to characterise pathological transcriptional signatures responsible for this. We show that endothelial cells (EC) are enriched for expression of genes associated with susceptibility to AD. Increased β-amyloid is associated with BBB impairment and a dysfunctional angiogenic response related to a failure of increased pro-angiogenic HIF1A to increased VEGFA signalling to EC. This is associated with vascular inflammatory activation, EC senescence and apoptosis. Our genomic dissection of vascular cell risk gene enrichment provides evidence for a role of EC pathology in AD and suggests that reducing vascular inflammatory activation and restoring effective angiogenesis could reduce vascular dysfunction contributing to the genesis or progression of early AD.
- 12 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-19
Top Cited PapersOpen AccessA single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer’s disease
Brain perfusion and blood-brain barrier (BBB) integrity are reduced early in Alzheimer’s disease (AD). We performed single nucleus RNA sequencing of vascular cells isolated from AD and non-diseased control brains to characterise pathological transcriptional signatures responsible for this. We show that endothelial cells (EC) are enriched for expression of genes associated with susceptibility to AD. Increased β-amyloid is associated with BBB impairment and a dysfunctional angiogenic response related to a failure of increased pro-angiogenic HIF1A to increased VEGFA signalling to EC. This is associated with vascular inflammatory activation, EC senescence and apoptosis. Our genomic dissection of vascular cell risk gene enrichment provides evidence for a role of EC pathology in AD and suggests that reducing vascular inflammatory activation and restoring effective angiogenesis could reduce vascular dysfunction contributing to the genesis or progression of early AD.